PT Royal Prima Tbk (IDX:PRIM)
Indonesia · Delayed Price · Currency is IDR 109.00
-1.00 (-0.91%)
Aug 12, 2026, 4:04 PM WIB
PT Royal Prima Tbk Financials Overview
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 320,785 | 338,906 | 299,357 | 265,337 | 261,933 | 599,964 |
Revenue Growth | -2.74% | 13.21% | 12.82% | 1.30% | -56.34% | 130.23% |
Gross Profit Gross Profit Growth | 73,388 | 72,800 | 74,204 | 75,236 | 96,267 | 179,101 |
Operating Income Operating Income Growth | -21,438 | -22,896 | -20,357 | -3,658 | 23,958 | 95,013 |
Net Income Net Income Growth | -19,116 | -21,817 | -18,408 | -2,747 | 21,589 | 75,434 |
Earnings Per Share EPS Growth | -5.65 | -6.43 | -5.42 | -0.81 | 6.37 | 22.23 |
EPS Growth | - | - | - | - | -71.34% | 97.66% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
RS Royal Prima Jambi RS Royal Prima Jambi Growth | 33,492 | 29,401 | 22,636 | 22,611 | 32,956 |
Rumah Sakit Marelan Rumah Sakit Marelan Growth | 38,652 | 40,198 | 46,082 | 40,063 | 33,867 |
RSU Royal Prima RSU Royal Prima Growth | 266,763 | 229,758 | 196,619 | 199,259 | 533,141 |
Total Total Growth | 338,906 | 299,357 | 265,337 | 261,933 | 599,964 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 21,718 | 14,529 | 20,716 | 26,493 | 64,405 | 262,687 |
Total Debt Total Debt Growth | - | - | - | - | - | 5.18 |
Net Cash (Debt) Net Cash Growth | 21,718 | 14,529 | 20,716 | 26,493 | 64,405 | 262,682 |
Net Cash Growth | -7.13% | -29.87% | -21.80% | -58.86% | -75.48% | 528.56% |
Net Cash Per Share Net Cash Per Share Growth | 6.42 | 4.28 | 6.10 | 7.81 | 19.01 | 77.42 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 9,212 | 4,138 | 46,982 | 21,267 | -100,631 | 233,250 |
Capital Expenditures CapEx Growth | -11,659 | -10,951 | -52,759 | -61,244 | -95,816 | -13,049 |
Free Cash Flow Free Cash Flow Growth | -2,448 | -6,813 | -5,777 | -39,977 | -196,447 | 220,200 |
Free Cash Flow Growth | - | - | - | - | - | 340.43% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 22.88% | 21.48% | 24.79% | 28.36% | 36.75% | 29.85% |
Operating Margin | -6.68% | -6.76% | -6.80% | -1.38% | 9.15% | 15.84% |
Pretax Margin | -6.01% | -6.72% | -6.45% | -0.90% | 10.64% | 16.78% |
Profit Margin | -5.96% | -6.44% | -6.15% | -1.03% | 8.24% | 12.57% |
FCF Margin | -0.76% | -2.01% | -1.93% | -15.07% | -75.00% | 36.70% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 27.16 | 17.99 |
P/FCF Ratio | - | - | - | - | - | 6.16 |
PS Ratio | 1.15 | 0.83 | 0.63 | 1.12 | 2.24 | 2.26 |